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Introduction
Malignant melanomas are tumors with the highest rates of car-
diac metastasis. However, cardiac metastasis is diagnosed in less 
than 1% of patients with malignant melanoma because less than 
10% of these patients present with cardiac symptoms.
1-3)
Identification of cardiac metastasis from melanoma usually 
means that the patient is suffering systemic metastasis. Unlike typi-
cal cardiac metastasized patients, we report a first case of a patient 
with a metastatic malignant melanoma in the heart without an id-
entifiable primary source or additional metastasis in Korea.
Case
A 59-year-old woman was admitted for cough and pleuritic chest 
pain with no history of malignancy or heart disease. Her initial blo-
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od pressure was 110/70 mm Hg, pulse rate 70 beats/min, respiratory 
rate 20/min, and body temperature was 36.1°C.
Jugular veins were not distended. No hepatomegaly or audible car-
diac murmurs were present. Laboratory studies, including a complete 
blood count, liver, and chemical profiles were in normal ranges. Elec-
trocardiography revealed a normal sinus rhythm. Chest radiography 
showed cardiomegaly without abnormal lesions in bilateral lung 
fields. Chest computed tomography showed a large amount of 
pericardial effusion and a mass in the right atrium (RA) (Fig. 1). Trans-
thoracic echocardiography showed a large mass measuring 42×31 
mm in the RA, which did not obstruct tricuspid valve flow. Her ejec-
tion fraction was normal (Fig. 2). Pericardiocentesis was performed. 
Effusion analysis showed a red blood cell count of 1.9×10
5/mm
3 and 
a white blood cell count of 3300/mm
3 (lymphocytes, 55%; neutro-
phils, 14%). No malignant cells in the pericardial fluid were noted. 
Cardiac MRI also revealed a large mass surrounding ascending aorta 
spread into transverse sinus and around pulmonary trunk (Fig. 3).
Instead of tumor resection, considering the risk of open heart sur-
gery and poor prognosis of extensive cardiac metastasis, pericardial 
window operation and epicardial mass biopsy were performed to 
relieve symptoms and confirm the pathological diagnosis. Patho-
logical analysis including immunohistochemistry revealed the final 
diagnosis to be malignant melanoma (Fig. 4). The primary cutaneous 
melanoma could not be identified despite careful dermatological 
examination. The patient had no history of halo nevus or mole re-
moval. Positron emission tomography revealed no other distant 
organ metastasis except for heart and mediastinal lymph nodes.279 Eun Young Lee, et al.
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Discussion
Malignant melanoma has aggressive biological behavior and the 
greatest tendency for metastasis to the heart.
1) Although autopsy 
studies reported an incidence of 50% to 71%, cardiac metastasis is 
diagnosed in less than 1% of patients with malignant melanoma be-
cause less than 10% of these patients present with cardiac symp-
toms.
2) Such metastases most frequently occur after multifocal he-
matological dissemination and may develop anywhere in the heart.
3) 
Melanotic metastases can invade the wall of any of the 4 cardiac 
chambers, and the RA is involved most frequently.
4)
The clinical signs and symptoms of cardiac metastasis are un-
clear and non-specific, although when present, the clinical signs and 
symptoms include fatigue, weakness, pericardial effusion, congestive 
heart failure, cardiac arrhythmia, superior vena cava syndrome, right 
ventricular outflow and inflow obstruction, and transient ischemic 
attack.
5) However, patients with malignant melanoma who have car-
diac metastases may present symptoms only caused by tumors in 
other organ systems. Although cardiac involvement occurs during 
the course of the disease, it is rare that the initial manifestation is 
cardiac metastasis.
A tumor’s anatomic location and extent of invasion determine the 
feasibility of surgical intervention, which should optimally be per-
formed during the early stages of the disease.
6) A complete resec-
tion of an intracardiac melanoma prevents potential morbidities 
that are associated with progressive intracardiac growth, such as 
superior vena cava syndrome, right ventricular outflow and inflow 
obstruction, dysrhythmia, cardiac tamponade, and heart failure.
6) 
Even when total resection is not possible, conservative surgery can 
relieve symptoms and prevent imminent cardiac failure. Conserva-
tive surgery improves the quality of a patient’s life, as in our pati-
ent’s case.
Although more than 90% of melanomas have a cutaneous ori-
gin,
7) melanomas may sometimes present metastatically in the ab-
sence of a primary lesion, termed melanomas of unknown primary 
origin. Most authors estimate that 2-6% of patients are diagnosed 
with metastatic melanoma of unknown primary site. In particular, 
such a metastatic melanoma in the heart such as in this patient wi-
thout a known primary cutaneous origin is a rare presentation and 
chiefly an anecdotal finding of metastatic melanoma. Several re-
ported cases can be found in the literature about cardiac involve-
ment with cutaneous primary malignant melanoma and multiple 
metastasis in Korea, as well as worldwide.
8)9) As far as we know, 
malignant cardiac melanoma without a primary origin has not yet 
been reported in Korea. 
The survival of patients with unknown primary melanoma was de-
monstrated to be similar to that of patients with known primary tu-
Fig. 1. Chest computed tomography. An inhomogeneous enhancing mass 
in the right atrium (arrow) and a massive amount of pericardial effusion 
were identified.
Fig. 3. Cardiac MRI. A large mass surrounding ascending aorta spread into 
transverse sinus and around pulmonary trunk and right pulmonary artery.
Fig. 2. Two-dimensional cardiac echocardiogram. In a subcostal view of the 
heart, a large mass measuring 42×31 mm was visualized in the right atrium.280  Malignant Melanoma of Unknown Primary Origin Presenting as Cardiac Metastasis
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mors when corresponding stages were compared.
10-12) Those patients 
with metastases to any other visceral sites are described to have a 
1 year survival rate of 41% and a median survival of approximately 
6 months.
11)13)14) Accordingly, we expected that the outcome of this 
patient might be very unfavorable. Although total resection was 
not possible because of extensive cardiac metastasis, a pericardial 
window operation could resolve her symptoms.
After surgery, chemotherapy was planned, including cisplatin, da-
carbazine, casmustine, and tamoxifen. However, the patient refused 
further chemotherapy after completion of two sessions. The patient 
has survived for 14 months after diagnosis. She is attending our 
hospital’s outpatient oncology department.
As only few reports about cardiac metastasis of malignant mela-
noma without cutaneous origin have been published, we are un-
certain if conservative surgery is associated with prolonged survival 
and if the role of surgery for survival is worth further investigation.
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Fig. 4. Pathology and immunohistochemistry of the pericardial biopsy. A: cytoplasmic melanin-pigmented cells and prominent nucleoli were found (×200). 
B: in immunohistochemistry, antibodies to HMB45 were positive (×200).
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